Stored Cross-Site Scripting Vulnerability in OpenEMR by OpenEMR
CVE-2021-25921

5.4MEDIUM

Key Information:

Vendor

Open-emr

Status
Openemr
Vendor
CVE Published:
22 March 2021

What is CVE-2021-25921?

OpenEMR versions between 2.7.3-rc1 and 6.0.0 are affected by a Stored Cross-Site Scripting vulnerability. This flaw occurs because user input is not properly validated in the Allergies section. An attacker can exploit this weakness by convincing an administrator to enter a crafted malicious payload, which could lead to unintended script execution in the web application. It is essential for users of these versions to implement security measures and apply necessary updates to mitigate the risks associated with this vulnerability.

Affected Version(s)

openemr 2.7.3-rc1, 2.8.0, 2.8.1, 2.8.2, 2.8.3, 2.9.0, 3.0.0, 3.0.1, 3.1.0, 3.2.0, 4.0.0, 4.1.0, 4.1.1, 4.1.2, 4.1.2.3, 4.1.2.6, 4.1.2.7, 4.2.0, 4.2.0.3, 4.2.1, 4.2.2, 5.0.0, 5.0.0.5, 5.0.0.6, 5.0.1, 5.0.1.1, 5.0.1.2, 5.0.1.3, 5.0.1.4, 5.0.1.5, 5.0.1.6, 5.0.1.7, 5.0.2, 5.0.2.1, 5.0.2.2, 5.0.2.3, 5.0.2.4, 6.0.0

References

https://github.com/openemr/openemr/commit/0fadc3e592d84bc...
x_refsource_MISC
https://www.whitesourcesoftware.com/vulnerability-databas...
x_refsource_MISC

EPSS Score

57% chance of being exploited in the next 30 days.

CVSS V3.1

Score:
5.4
Severity:
MEDIUM
Confidentiality:
Low
Integrity:
Low
Availability:
Low
Attack Vector:
Network
Attack Complexity:
Low
Privileges Required:
Low
User Interaction:
Required
Scope:
Changed

Timeline

  • Vulnerability published

  • Vulnerability Reserved

.